Dynamic Interleukin-6 Level Changes as a Prognostic Indicator in Patients With COVID-19
Open Access
- 17 July 2020
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 11, 1093
- https://doi.org/10.3389/fphar.2020.01093
Abstract
Background: Interleukin-6 (IL-6), a proinflammatory cytokine, has been reported to be associated with disease severity and mortality in patients with coronavirus disease 2019 (COVID-19). Yet, dynamic changes in IL-6 levels and their prognostic value as an indicator of lung injury in COVID-19 patients have not been fully elucidated. Objective: To validate whether IL-6 levels are associated with disease severity and mortality and to investigate whether dynamic changes in IL-6 levels might be a predictive factor for lung injury in COVID-19 patients. Methods: This retrospective, single-center study included 728 adult COVID-19 patients and used data extracted from electronic medical records for analyses. Results: The mortality rate was higher in the elevated IL-6 group than in the normal IL-6 group (0.16 vs 5%). Cox proportional hazards and logistic regression analyses for survival (adjusted hazard ratio, 10.39; 95% confidence interval [CI], 1.09–99.23; p = 0.042) and disease severity (adjusted odds ratio, 3.56; 95% CI, 2.06–6.19; p < 0.001) revealed similar trends. Curve-fitting analyses indicated that patient computed tomography (CT) scores peaked on days 22 and 24. An initial decline in IL-6 levels on day 16 was followed by resurgence to a peak, nearly in tandem with the CT scores. Conclusion: Increased IL-6 level may be an independent risk factor for disease severity and in-hospital mortality and dynamic IL-6 changes may serve as a potential predictor for lung injury in Chinese COVID-19 patients. These findings may guide future treatment of COVID-19 patients.Keywords
This publication has 22 references indexed in Scilit:
- Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 CasesRadiology, 2020
- COVID-19 in a designated infectious diseases hospital outside Hubei Province, ChinaAllergy, 2020
- Elevated interleukin-6 and severe COVID-19: A meta-analysisJournal of Medical Virology, 2020
- COVID-19 cytokine storm: the interplay between inflammation and coagulationThe Lancet Respiratory Medicine, 2020
- Tocilizumab for the treatment of severe coronavirus disease 2019Journal of Medical Virology, 2020
- Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL ScoreClinical Infectious Diseases, 2020
- Clinical and immunological features of severe and moderate coronavirus disease 2019JCI Insight, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- The micromechanics of lung alveoli: structure and function of surfactant and tissue componentsHistochemistry and Cell Biology, 2018
- Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndromeRespirology, 2006